Felis ISSN 2398-2950

Pancuronium

Contributor(s): John Dodam, Vetstream Ltd

Introduction

Name

  • Pancuronium.

Class of drug

  • Non-depolarizing neuromuscular blocking agent.

Uses

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Indications

  • Profound skeletal muscle relaxation when modest cardiovascular stimulation required.
  • In patients undergoing mechanical ventilation.

Administration

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Pharmacokinetics

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Precautions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Interactions

with other drugs

Drugs which may antagonize the effects of pancuronium

  • Acetylcholine.
  • Aminoglycosides.
  • Anticholinesterases (pyridostigmine, neostigmine).
  • Azlocillin.
  • Azathioprine.
  • Clindamycin.
  • Lincomycin.
  • Polymyxin.
  • Potassium - low potassium may enhance effects.
  • Theophylline.

Suxamethonium

  • May enhance muscular relaxation (delay the administration of pancuronium until the effects of suxamethonium begin to diminish).

Drugs which may enhance the action of pancuronium

  • Some antibiotics, eg aminoglycosides, clindamycin, lincomycin.
  • Inhalational anesthetics, eg halothane, methoxyflurane.
    Duration of action is longer when isoflurane rather than halothane is used to maintain anesthesia.
  • Magnesium salts.
  • Quinidine.

Adverse Reactions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Further Reading

Publications

Refereed papers

Other sources of information

  • Ramsey I (2017) BSAVA Small Animal Formulary. 9th edn. 
  • Based on Small Animal Formulary. Tennant, Bryn (1999) 3rd edn. Cheltenham: BSAVA.

ADDED